These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37952084)

  • 1. Recent application of CRISPR-Cas12 and OMEGA system for genome editing.
    Badon IW; Oh Y; Kim HJ; Lee SH
    Mol Ther; 2024 Jan; 32(1):32-43. PubMed ID: 37952084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanzor is a eukaryotic programmable RNA-guided endonuclease.
    Saito M; Xu P; Faure G; Maguire S; Kannan S; Altae-Tran H; Vo S; Desimone A; Macrae RK; Zhang F
    Nature; 2023 Aug; 620(7974):660-668. PubMed ID: 37380027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated gene therapies by miniature gene editing tools.
    Kong X; Li T; Yang H
    Sci China Life Sci; 2024 Sep; ():. PubMed ID: 39388062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress on nucleic acid detection and genome editing of CRISPR/Cas12 system.
    Yang Y; Wang D; Lü P; Ma S; Chen K
    Mol Biol Rep; 2023 Apr; 50(4):3723-3738. PubMed ID: 36648696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing using CRISPR, CAST, and Fanzor systems.
    Song B; Bae S
    Mol Cells; 2024 Jul; 47(7):100086. PubMed ID: 38909984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TnpB structure reveals minimal functional core of Cas12 nuclease family.
    Sasnauskas G; Tamulaitiene G; Druteika G; Carabias A; Silanskas A; Kazlauskas D; Venclovas Č; Montoya G; Karvelis T; Siksnys V
    Nature; 2023 Apr; 616(7956):384-389. PubMed ID: 37020015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity, evolution, and classification of the RNA-guided nucleases TnpB and Cas12.
    Altae-Tran H; Shmakov SA; Makarova KS; Wolf YI; Kannan S; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2308224120. PubMed ID: 37983496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications.
    Tang N; Ji Q
    ACS Chem Biol; 2024 Jul; 19(7):1399-1408. PubMed ID: 38899980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing.
    Tao J; Bauer DE; Chiarle R
    Nat Commun; 2023 Jan; 14(1):212. PubMed ID: 36639728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Family-Specific Features in Cas9 and Cas12 Proteins: A Machine Learning Approach Using Complete Protein Feature Spectrum.
    Madugula SS; Pujar P; Nammi B; Wang S; Jayasinghe-Arachchige VM; Pham T; Mashburn D; Artiles M; Liu J
    J Chem Inf Model; 2024 Jun; 64(12):4897-4911. PubMed ID: 38838358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
    Khanzadi MN; Khan AA
    J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
    Koonin EV; Gootenberg JS; Abudayyeh OO
    Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems.
    Aquino-Jarquin G
    Drug Discov Today; 2023 Nov; 28(11):103793. PubMed ID: 37797813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
    Yang F; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing.
    Hossain MA
    Prog Mol Biol Transl Sci; 2021; 178():63-83. PubMed ID: 33685600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.